43 (7) 30 (7) 14 (4) 1-5 (0.6)
Ulcerative colitis Active (n=41) 73 (8) 44 (8) 31 (9) 14 (4) 1-6(0.7)
Inactive (n= 19) 76 (9) 45 (7) 35 (8) 11 (4)*
1-4(0 5)
Crohn's disease Active (n= 12) 74 (8) 44 (10) 31 (11) 13 (5) 1-6(0.7)
Inactive (n-19) 76 (10) 45 (12) 31 (9) 10 (4)** 1-6(0.7) *p<0.05, **p<O-OOl. (7) 10 (3) 17 (6) 25 (6) 14 (5) 16 (5) Ulcerative colitis Active 35 (8) 9 (3) 18 (9) 27 (8) 13 (4) 18 (9) Inactive 35 (7) 10 (4) 13 (5) (11) 11 (5) 18 (9) 26 (8) 11 (4) 20 (11 lymphocytes in inflammatory bowel disease were increased compared with control subjects, this difference was not significant (Table V) . Cytotoxic lymphocyte subsets identified by monoclonal antibodies Leu-7, Leu-11 (CD16), and Leu-19 were also investigated (Table VI) . There was no significant difference in the proportion of cytotoxic T lymphocytes between control subjects and patients with inflammatory bowel disease. Natural killer cells (CD3-, CD16+, Leu-19+) were significantly decreased in patients with active Crohn's disease (p<005). The proportion of Leu-7+, CD8+ lymphocytes and Leu-7+, CD3+ cells was significantly higher in inactive disease groups than in control subjects (inactive ulcerative colitis: p<OOOl, inactive Crohn's disease: p<O005).
Examination of B cell subsets showed a decrease in the proportion of Leu-1+ (CD5) B cells (Table VII) . A significantly lower proportion of Leu-8+ B cells was present in inactive Crohn's disease compared with control subjects (p<0O 1). Loss of antigens has been shown to be associated with initial activation of B cells. In active inflammatory bowel disease, there was no difference in the proportion of B cells expressing FceR (CD23), but in inactive disease the proportion of these cells was significantly decreased compared with that in control subjects (inactive ulcerative colitis: p<O005, inactive Crohn's disease: p<OO1). Leu In many patients with autoimmune disorders, the CD4/CD8 ratio is increased, reflecting a relative or absolute deficiency of CD8 + cells. 16 17 Although CD8+ lymphocytes were low in inactive ulcerative colitis, the CD4/CD8 ratio did not change.
In previous studies cells with the CD4+, Leu-8-phenotype have been shown to contain the majority of helper function involved in B cell differentiation into plaque forming cells.' In patients with inflammatory bowel disease the ratio of CD4+ Leu-8-to CD4 Leu-8+ cells remained unchanged. The CD4+ cells can be subdivided by monoclonal antibodies reacting with different epitopes of the high molecular weight T200 common leucocyte antigen (CD45R). These monoclonal antibodies are Leu-18,'8 2H4,'9 and 3AC5 and G1-5.20 The CD4+ cells expressing the CD45R antigen have been reported to possess a T suppressor-inducer function, whereas those helper cells lacking CD45R show a CD4+ inducer function. ' 
